🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07618416
Recruiting Observational

Machine Learning Model Based on Baroreflex Sensitivity for Predicting Post-Induction Hypotension in Elderly Patients

NCT07618416 · tracked via the Priya Life Science China tracker
Sponsor
Peking Union Medical College Hospital
Phase
Observational
Started
2026-06-01
Last updated
2026-06-01

Condition(s) studied

Post Induction Hypotension

Study summary

The purpose of this study is to develop a high-performance machine learning model combining dynamic baroreflex sensitivity (BRS) metrics and multi-dimensional static clinical features to predict the risk of post-induction hypotension (PIH) in elderly patients undergoing elective non-cardiac surgery under general anesthesia.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Aged over 65 years; * Scheduled for elective non-cardiac surgery; * American Society of Anesthesiologists (ASA) physical status classification I-III; * Planned for general anesthesia with endotracheal intubation; * Patient and legal guardians are capable of understanding the study protocol and willing to provide written informed consent. Exclusion Criteria: * Severe peripheral vascular diseases; * Secondary hypertension; * Presence of physical tremors (e.g., Parkinson's disease) preventing stable recording; * Inability to accurately measure upper limb blood pressure; * Pre-existing cardiac arrhythmias (e.g., atrial fibrillation) that render BRS; * Psychiatric disorders or cognitive impairments hindering basic cooperation.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Peking Union Medical College Hospital Beijing China Recruiting

More Peking Union Medical College Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07618416 on ClinicalTrials.gov ↗ ← All trials in China